Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

And although shares fell 35% from peak-to-trough, it became apparent that those who seek these weight-loss drugs also tend to have sleep apnea and need ongoing treatment from ResMed's products. Since ...

The great quarter was driven by high demand for sleep-related products and growth in digital health solutions. As a specialist in sleep and respiratory health, ResMed built its reputation through ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

Worcester Sleep Dentistry - Auburn offers specialized dental solutions for snoring and sleep apnea, helping patients breathe ...

You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate ...

There’s no question that sleep is important for your health. Without enough of it, your risk of developing diseases such as ...